Evidence map›Paper›PMID 36252159›Full record

ReviewJCO global oncology2022

Innovative Methodology for Strengthening a Multidisciplinary Team Approach in Cities in Low- and Middle-Income Countries.

Vanessa Eaton, Angela Zambrano, Valeria Sanabria, Roberto Lopez, Ishmael Kyei, Rai Mra, Vanessa Sarchet, Megan Kremzier, Josep Borras, Thet Ko Aung and 3 more

Abstract readReview
In one paragraph

Review in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Improving Access to Radiotherapy in Gauteng: A Framework for Equitable Cancer Care.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vanessa EatonAmerican Society for Clinical Oncology, Alexandria, VA.
Angela ZambranoFundación Valle Del Lili, Cali, Colombia.ORCID 0000-0003-0846-8129
Valeria SanabriaHospital Nacional de Itauguá del MoH-Hospital de Clínicas de la Universidad Nacional de Asunción-Centro Médico La Costa, Asunción, Paraguay.
Roberto LopezCentro Médico La Costa, Asunción, Paraguay.
Ishmael KyeiKomfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID 0000-0002-8419-8637
Rai MraMyanmar Medical Association, Yangon, Myanmar.
Vanessa SarchetAmerican Society for Clinical Oncology, Alexandria, VA.
Megan KremzierAmerican Society for Clinical Oncology, Alexandria, VA.
Josep BorrasDepartment of Health, Catalonia, Spain.
Thet Ko AungCity Cancer Challenge, Geneva, Switzerland.ORCID 0000-0002-6222-7994
Rebecca Morton DohertyCity Cancer Challenge, Geneva, Switzerland.ORCID 0000-0002-1464-542X
Susan HenshallCity Cancer Challenge, Geneva, Switzerland.ORCID 0000-0002-1293-0091
Rolando CamachoCity Cancer Challenge, Geneva, Switzerland.ORCID 0000-0002-8394-4327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDelivering high-quality cancer care to patients through a multidisciplinary team (MDT) care approach remains a challenge, particularly in low- and middle-income countries characterized by fragmented health systems and limited human resources for cancer care. City Cancer Challenge (C/Can) is supporting cities in low- and middle-income countries as they work to improve access to equitable quality cancer care. C/Can has developed an innovative methodology to address the MDT gap, piloted in four cities-Asunciòn, Cali, Kumasi, and Yangon.

methodsCollaborating with a network of partners, C/Can and ASCO have developed a package of technical cooperation support focusing on two priority areas that have emerged as core needs: first developing consensus-based, city-wide patient management guidelines for the most common cancers and second, building capacity for the implementation of MDTs in institutions providing cancer care in the city.

resultsThe real-time application of C/Can's MDT approach in Cali and Asuncion underlined the importance of engaging the right stakeholders early on and embedding MDT guidelines in local and national regulatory frameworks to achieve their sustainable uptake. The results in Cali and Asuncion were essential for informing the process in Yangon, asserting the clear benefits of city-to-city knowledge exchange. Finally, the global COVID-19 pandemic prompted a rapid adaptation of the methodology from an in-person to virtual format; the unexpected success of the virtual program in Kumasi has led to its application in subsequent C/Can cities.

conclusionThe application of C/Can's methodology in this first set of cities has reinforced not only the importance of both resource appropriate guidelines and a highly trained health workforce but also the need for commitment to work across institutions and disciplines.

Indexed as

COVID-19NeoplasmsCitiesDeveloping CountriesHumansPandemicsPatient Care Team

Identifiers

PMID36252159
PMCPMC9812446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.